Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KLAC vs GSK✓SelectedUSD · GSKKLAC vs GSK performance historyLatest closeAs of-3.17%11/13
Stock and ETF performance explorer

KLAC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+286.1%
GSK return
+44.4%
Excess return
+241.7%
Maximum drawdown
-56.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.2%+0.5%-3.7%-3.2%
7D+10.0%+1.1%+8.8%+9.8%
30D-14.8%+6.3%-21.2%-15.6%
3M-27.2%+1.8%-29.0%-27.5%
6M-17.5%+1.7%-19.1%-18.1%
YTD+25.8%+6.5%+19.3%+23.7%
1Y+31.8%+9.5%+22.3%+28.8%
3Y+195.3%+65.3%+130.0%+159.1%
All+286.1%+44.4%+241.7%+233.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling